Shares of Xylem Inc (NYSE:XYL) have received a consensus rating of “Buy” from the fifteen brokerages that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and ten have issued a buy recommendation on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $77.92.
XYL has been the subject of several recent analyst reports. Vertical Research downgraded Xylem from a “hold” rating to a “sell” rating in a report on Monday, October 8th. Credit Suisse Group began coverage on Xylem in a report on Friday, October 12th. They set an “outperform” rating and a $86.00 price target for the company. Berenberg Bank began coverage on Xylem in a report on Wednesday, October 3rd. They set a “sell” rating and a $65.00 price target for the company. Royal Bank of Canada reaffirmed a “buy” rating and set a $77.00 price target on shares of Xylem in a report on Wednesday, October 31st. Finally, Oppenheimer reaffirmed a “buy” rating on shares of Xylem in a report on Tuesday, October 30th.
Shares of NYSE XYL traded up $2.19 during trading hours on Wednesday, hitting $66.58. The company had a trading volume of 360,533 shares, compared to its average volume of 982,274. The company has a market cap of $11.56 billion, a PE ratio of 27.74, a PEG ratio of 1.24 and a beta of 1.28. The company has a current ratio of 1.49, a quick ratio of 1.07 and a debt-to-equity ratio of 0.83. Xylem has a 1-year low of $63.71 and a 1-year high of $82.44.
The firm also recently declared a quarterly dividend, which was paid on Friday, December 7th. Shareholders of record on Thursday, November 1st were issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 1.26%. The ex-dividend date of this dividend was Wednesday, October 31st. Xylem’s dividend payout ratio is 35.00%.
A number of institutional investors have recently made changes to their positions in XYL. Federated Investors Inc. PA increased its position in Xylem by 472.9% during the 3rd quarter. Federated Investors Inc. PA now owns 118,947 shares of the industrial products company’s stock worth $9,501,000 after buying an additional 98,184 shares during the period. Legal & General Group Plc increased its position in Xylem by 10.6% during the 3rd quarter. Legal & General Group Plc now owns 950,436 shares of the industrial products company’s stock worth $75,911,000 after buying an additional 91,099 shares during the period. Standard Life Aberdeen plc increased its position in Xylem by 17.3% during the 3rd quarter. Standard Life Aberdeen plc now owns 49,180 shares of the industrial products company’s stock worth $3,928,000 after buying an additional 7,252 shares during the period. Rehmann Capital Advisory Group increased its position in Xylem by 7,887.0% during the 3rd quarter. Rehmann Capital Advisory Group now owns 15,974 shares of the industrial products company’s stock worth $200,000 after buying an additional 15,774 shares during the period. Finally, Paradigm Asset Management Co. LLC bought a new position in Xylem during the 3rd quarter worth $188,000. 83.92% of the stock is owned by institutional investors and hedge funds.
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
Recommended Story: Short Selling Stocks and Day Traders
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.